A Population-Based Seroepidemiological Study of Cervical Cancer

Cancer Research

Volumn 54, Issue 1, 1994, Pages 134-141

  Dillner, Joakim ^a   Lenner, Per ^b   Lehtinen, Matti ^c   Eklund, Carina ^a   Heino, Pirkko ^a   Wiklund, Fredrik ^b   Hallmans, Goran ^b   Stendahl, Ulf ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIGEN;

ANTIBODY BLOOD LEVEL; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS 1; HUMAN; MAJOR CLINICAL STUDY; OPEN READING FRAME; PAPILLOMA VIRUS; PRIORITY JOURNAL; RISK FACTOR; SEROEPIDEMIOLOGY; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; AGE FACTORS; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CASE-CONTROL STUDIES; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PARITY; SEROEPIDEMIOLOGIC STUDIES; SIMPLEXVIRUS; SMOKING; SWEDEN; UTERINE CERVICAL NEOPLASMS;

EID: 0028120942     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. zur Hausen, H. Viruses in human cancers. Science (Washington DC), 254: 1167–1173, 1991.
2. Pfister, H. Human papillomaviruses and genital cancer. Adv. Cancer Res. 48: 113–147, 1987.
3. Dillner, J. Dillner, L. Utter, G. Eklund, C. Rotola, A. Costa, S., and DiLuca, D. Mapping of linear epitopes of human papillomavirus type 16: the LI and L2 open reading frames. Int. J. Cancer, 45: 529–535, 1990.
4. Dillner, J. Mapping of linear epitopes of human papillomavirus type 16: the El, E2, E4, E5, E6 and E7 open reading frames. Int. J. Cancer, 46: 703–711, 1990.
5. Krchnak, V. Vagner, J. Suchankova, A. Krcmar, M. Ritterova, L., and Vonka, V. Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA.J. Gen. Virol. 71: 2719–2724, 1990.
6. Muller, M. Gausepohl, H. de Martynoff, G. Frank, R. Brasseur, R., and Gissmann, L. Identification of seroreactive regions of the human papillomavirus type 16 proteins E4, E6, E7 and LI.J. Gen. Virol, 71: 2709–2717, 1990.
7. Yaegashi, N. Jenison, S. A. Batra, M., and Galloway, D. A. Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11. J. Virol, 66: 2008–2019, 1992.
8. Dillner, J. Dillner, L. Robb, J. Willems, J. Jones, I. Lancaster, W. Smith, R., and Lerner, R. A synthetic peptide defines a serologic IgA response to a human papillo-mavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proc. Natl. Acad. Sci. USA, 86: 3838–3841, 1989.
9. Lehtinen, M. Leminen, A. Paavonen, J. Lehtovirta, P. Hyöty, H. Vesterinen, E., and Dillner, J. Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma. J. Clin. Pathol, 45: 494–497, 1992.
10. Muller, M. Viscidi, R. P. Sun, Y. Guerrero, E. Hill, P. M. Shah, F. Bosch, F. X. Munoz, N. Gissmann, L., and Shah, K. V. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16 associated invasive cervical carcinoma. Virology, 757: 508–514, 1992.
11. Jochmus-Kudielka, I. Schneider, A. Braun, R. Kimmig, R. Koldovsky, U. Schne-weis, K. E. Seedorf, K., and Gissman, L. Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J. Natl. Cancer Inst, 81: 1698–1704, 1989.
12. Mann, V M, Loo de Lao, S. Brenes, M. Brinton, L. A. Rawls, J. A. Green, M. Reeves, W. C., and Rawls, W. E. Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Res, 50: 7815–7819, 1990.
13. Jenison, S. A. Yu, X. P. Valentine, J. M. Koutsky, A. Christiansen, A. E. Beckmann, A. M., and Galloway, D. A. Evidence of prevalent genital-type human papillomavirus infections in adults and children. J. Infect. Dis, 162: 60–69, 1990.
14. Dillner, L. Heino, P. Moreno-Lopez, J., and Dillner, J. Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses. J. Virol, 65: 6862–6870, 1991.
15. Wikstrom, A. Eklund, C. von Krogh, G. Lidbrink, P., and Dillner, J. Levels of immunoglobulin G antibodies against defined epitopes of the LI and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata. J. Clin. Microbiol, 30: 1795–1800, 1992.
16. Schiffman, M. H. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J. Natl. Cancer Inst, 84: 394–398, 1992.
17. Granström, M. Julander, I. G. Hedstrom, S. A. and Möllby, R. Enzyme-linked immunosorbent assay for antibodies against teichoic acid in patients with staphylococcal infections. J. Clin. Microbiol, 17: 640–646, 1983.
18. Novak, J. Sova, P. Krchnak, V. Hamsikova, E. Zavadova, H., and Roubal, J. Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp. 50 using synthetic peptides. J. Gen. Virol, 72: 1409–1413, 1991.
19. Dillner, J. Sternas, L. Kallin, B. Alexander, H. Ehlin-Henriksson, B. Jornvall, H. Klein, G., and Lerner, R. Antibodies against a synthetic peptide identify the Epstein-Barr virus determined nuclear antigen. Proc. Natl. Acad. Sci. USA, 81: 4652–4656, 1984.
20. Linde, A. Kallin, B. Dillner, J. Andersson, J. Jagdahl, L. Lindvall, A., and Wahren, B. Evaluation of ELISAs with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. J. Infect. Dis, 161: 903–909, 1990.
21. Lehtinen, M. Koivisto, V. Lehtinen, T. Paavonen, J., and Leinikki, P. Immunoblot-ting and ELISA analysis of serological responses in HSV-1 and HSV-2 infected patients. Intervirology, 25: 37–43, 1985.
22. Rawls, W. E. Iwamoto, K. Adam, E., and Melnick, J. L. Measurement of antibodies to herpes-virus types 1 and 2 in human sera. J. Immunol, 104: 599–606, 1970.
23. Sanchez-Martinez, D. Schmid, D. S. Whittington, W. Brown, D. Reeves, W. C. Chatterjee, S. Whitley, R. J., and Pellett, P. E. Evaluation of a test based on bacu-lovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J. Infect. Dis, 164: 1196–1199, 1991.
24. Lehtinen, M. Leminen, A. Kuoppala, T. Tiikkainen, M. Lehtinen, T. Lehtovirta, P. Punnonen, R. Vesterinen, E., and Paavonen, J. Pre- and posttreatment serum antibody responses to HPV 16 E2 and HSV 2ICP8 proteins in women with cervical carcinoma. J. Med. Virol, 37: 180–186, 1992.
25. Lehtinen, M. Hakama, M. Aaran, R. K. Aromaa, A. Knekt, P. Leinikki, P. Maatela, J. Peto, R., and Teppo, L. Herpes simplex virus type 2 infection and cervical cancer: a prospective study of 12 years of follow-up in Finland. Cancer Causes Control, 3: 333–338, 1992.
26. Lehtinen, M. Parkkonen, P. Luoto, H. Ylä-Outinen, A. Romppanen, U. Rantala, I., and Paavonen, J. Antipeptide IgA antibodies to a human papillomavirus type 16 E2 derived synthetic peptide predict the natural history of cervical HPV infection. Serono Symp. Publ. Raven Press, 78: 509–519, 1990.
27. Reeves, W. C. Rawls, J. A. Green, M., and Rawls, W E. Antibodies to human papillomavirus type 16 in patients with cervical neoplasia. Lancet, 1: 551–552, 1990.
28. Suchankova, A. Ritter, O. Hirsch, I. Krchnak, V. Kalos, Z. Hamsikova, E. Brichacek, B., and Vonka, V Presence of antibody reactive with synthetic peptide derived from L2 open reading frame of human papillomavirus type 6b and 11 in human sera. Acta Virol. (Prague) (Engl. Ed.), 34: 433–442, 1990.
29. Heino, P. Goldman, S. Lagerstedt, U., and Dillner, J. Molecular and serological studies of human papillomavirus among patients with anal epidermoid carcinoma. Int. J. Cancer, 53: 377–381, 1993.
30. Dillner, L. Persson, E. Fredriksson, A. Forslund, O. Hansson, B. G., and Dillner, J. Antibodies against papillomavirus-derived antigens in cervical secretions from women with genital condylomas. J. Clin. Microbiol, 30: 1795–1800, 1993.
31. Suchankova, A. Krchnak, V. Vagner, J. Hamsikova, E. Krcmar, M. Ritterova, L., and Vonka, V Epitope mapping of the human papillomavirus type 16 E4 protein by means of synthetic peptides. J. Gen. Virol, 73: 429–432, 1992.
32. Jenison, S. A. Yu, X. P. Valentine, J. A., and Galloway, D. A. Human antibodies react with an epitope of the human papillomavirus type 6b LI open reading frame which is distinct from the type-common epitope. J. Virol, 63: 809–818, 1989.
33. Smiley, L., and Huang, E. S. Cytomegalovirus as a sexually transmitted disease. In: K. K. Holmes, P. A. Mårdh, and P. E Sparling (eds.), Sexually Transmitted Diseases, Ed. 2, pp. 415–423. New York: McGraw-Hill, 1990.
34. Koutsky, L. A. Holmes, K. K. Critchlow, C. W. Stevens, C. E. Paavonen, J. Beckmann, A. M. DeRouen, T. A. Galloway, D. A. Vernon, D., and Kiviat, N. B. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med, 327: 1272–1278, 1992.
35. Brinton, L. A. Schairer, C. Haenszel, W. Stolley, P. Levine, H., and Savitz, D. A. Cigarette smoking and invasive cervical cancer. JAMA, 255: 3265–3269, 1986.
36. Lehtinen, M. Niemelä, J. Dillner, J. Parkkonen, P. Nummi, T. Liski, E. Nieminen, P. Reunala, T., and Paavonen, J. Evaluation of serum antibody response to a newly identified B-cell epitope in the minor nucleocapsid protein L2 of human papillomavirus type 16. Clin. Diagn. Virol, 1: 153–165, 1993.
37. zur Hausen, H. Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events. Lancet, 2: 1370–1372, 1982.
38. Hildesheim, A. Mann, V. Brinton, L. A. Szklo, M. Reeves, W. C., and Rawls, W. Herpes-simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer. Int. J. Cancer, 49: 335–340, 1991.
39. Schmauz, R. Okong, P. and de Villiers, E. M. Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int. J. Cancer, 43: 805–809, 1989.
40. Evans, B. A. Bond, R. A., and MacRae, K. D. A colposcopy case-control study of cervical squamous intraepithelial lesions in women with anogenital warts. Genitourin. Med. 68: 300–304, 1992.
41. Baird, P. J. Serological evidence for the association of papillomavirus and cervical neoplasia. Lancet, 2: 17, 18, 1983.
42. DiLuca, D. Costa, S. Monini, P. Rotola, A. Terzano, P. Savioli, A. Grigioni, W., and Cassai, E. Search for human papillomavirus, herpes simplex virus and c-myc oncogene in human genital tumors. Int. J. Cancer, 43: 570–577, 1989.
43. Dillner, L. Moreno-Lopez, J., and Dillner, J. Serological responses to papillomavirus group-specific antigens in women with neoplasia of the cervix uteri. J. Clin. Microbiol. 28: 624–627, 1990.
44. Cullen, A. P. Reid, R. Campion, M., and Lorincz, A. T. Analysis of the physical stage of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasias. J. Virol. 65: 606–612, 1991.
45. Gustafsson, L., and Adami, H. O. Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br. J. Cancer, 60: 132–141, 1989.
46. Dillner, J. Disappearance of antibodies to HPV 16 E7 after treatment for cervical cancer. Lancet, 341: 1594, 1993.